Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs THC✓SelectedUSD · THCMRNA vs THC performance historyLatest closeAs of-3.93%11/17
Stock and ETF performance explorer

MRNA vs THC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+161.9%
THC return
+348.9%
Excess return
-187.0%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioTHCExcessAlpha
1D-3.9%-3.2%-0.7%-3.4%
7D-17.6%-2.8%-14.7%-17.2%
30D-5.1%+5.5%-10.7%-5.8%
3M+220.8%+6.6%+214.2%+217.4%
6M+321.7%+43.4%+278.3%+294.4%
YTD+601.3%+41.9%+559.3%+552.7%
1Y+735.2%+46.6%+688.6%+669.9%
All+161.9%+348.9%-187.0%+57.8%

Cumulative growth

Daily Returns

Daily percentage return beside THC.

Daily Out/Under-Performance

Portfolio return minus THC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling